KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Supernus Pharmaceuticals (SUPN) over the last 11 years, with Q3 2025 value amounting to 0.03%.

  • Supernus Pharmaceuticals' Return on Invested Capital fell 800.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 0.06% for FY2024, which is 600.0% up from last year.
  • As of Q3 2025, Supernus Pharmaceuticals' Return on Invested Capital stood at 0.03%, which was down 800.0% from 0.05% recorded in Q2 2025.
  • In the past 5 years, Supernus Pharmaceuticals' Return on Invested Capital registered a high of 0.15% during Q1 2021, and its lowest value of 0.04% during Q1 2024.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.05% (2025), whereas its average is 0.05%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first tumbled by -1000bps in 2021, then skyrocketed by 800bps in 2025.
  • Supernus Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.06% in 2021, then tumbled by -31bps to 0.04% in 2022, then crashed by -106bps to 0.0% in 2023, then surged by 2380bps to 0.06% in 2024, then crashed by -155bps to 0.03% in 2025.
  • Its Return on Invested Capital stands at 0.03% for Q3 2025, versus 0.05% for Q2 2025 and 0.05% for Q1 2025.